Why Trial Expertise Makes Or Breaks Clinical AI

Agentic AI is rapidly moving from concept to practical application in clinical research, promising to reduce administrative burden, improve efficiency, and help teams focus on higher-value work. But as sponsors and CROs evaluate a growing field of AI providers, an important distinction is emerging: technical sophistication alone may not be enough.

Clinical trials operate within a highly specialized environment defined by rigorous regulations, established workflows, and complex operational requirements. Success depends not only on what AI can do, but also on whether it understands the language, processes, and realities of clinical development. Real-world deployments are beginning to reveal measurable gains in areas such as document management and clinical monitoring, while underscoring the importance of clinical expertise alongside AI innovation. As agentic AI adoption accelerates, organizations must consider whether their technology partners bring both advanced capabilities and deep trial experience to the table.

Explore what early results reveal about the future of AI-powered trials and the qualities that may separate meaningful impact from hype.